Skip to main content
letter
. 2023 Apr 4;38(8):2015–2017. doi: 10.1007/s11606-023-08187-3

Table 1.

Patient Characteristics Stratified by Normal/Mild Versus Moderate/Severe Sleep Disturbance

Characteristic Total
(N = 962)
Normal/mild sleep disturbance
(N = 565)
Moderate/severe sleep disturbance
(N = 397)
p-value
Age 49.6 ± 13.7 50.0 ± 14.5 49.1 ± 12.5 0.31a2
Gender 0.41c
  Female 721 (74.9) 418 (74.0) 303 (76.3)
  Male 241 (25.1) 147 (26.0) 94 (23.7)
Race 0.003c
  White 788 (81.9) 483 (85.5) 305 (76.8)
  Black 125 (13.0) 60 (10.6) 65 (16.4)
  Other 49 (5.1) 22 (3.9) 27 (6.8)
BMI (kg/m2)* 31.6 ± 7.7 31.2 ± 7.5 32.1 ± 8.0 0.11a1
Time since positive test, (months) 6.7 ± 4.2 6.8 ± 4.2 6.5 ± 4.2 0.28a1
Comorbidities
  Asthma 149 (15.5) 79 (14.0) 70 (17.6) 0.12c
  Chronic fatigue 4 (0.42) 2 (0.35) 2 (0.50) 0.99d
  COPD 21 (2.2) 12 (2.1) 9 (2.3) 0.88c
  Coronary artery disease 28 (2.9) 12 (2.1) 16 (4.0) 0.083c
  Dementia 1 (0.10) 0 (0.00) 1 (0.25) 0.41d
  Diabetes 77 (8.0) 38 (6.7) 39 (9.8) 0.081c
  Heart failure 13 (1.4) 8 (1.4) 5 (1.3) 0.84c
  Hypertension 202 (21.0) 118 (20.9) 84 (21.2) 0.92c
  Interstitial lung disease 3 (0.31) 0 (0.00) 3 (0.76) 0.070d
  Obesity 85 (8.8) 52 (9.2) 33 (8.3) 0.63c
  Pulmonary embolism 21 (2.2) 12 (2.1) 9 (2.3) 0.88c
  Pulmonary hypertension 5 (0.52) 5 (0.88) 0 (0.00) 0.081d
  Systemic lupus erythematosus 9 (0.94) 3 (0.53) 6 (1.5) 0.17d
COVID-19 severity
  Hospitalization 0.017c
    Missing 16 (1.7) 10 (1.8) 6 (1.5)
    No 683 (71.0) 420 (74.3) 263 (66.2)
    Yes 263 (27.3) 135 (23.9) 128 (32.2)
  Intensive care unit stay 0.98c
    Missing 13 (1.4) 8 (1.4) 5 (1.3)
    No 898 (93.3) 527 (93.3) 371 (93.5)
    Yes 51 (5.3) 30 (5.3) 21 (5.3)
  Mechanical ventilation 0.99c
    Missing 14 (1.5) 8 (1.4) 6 (1.5)
    No 929 (96.6) 546 (96.6) 383 (96.5)
    Yes 19 (2.0) 11 (1.9) 8 (2.0)
Patient-reported outcomes
  GAD-2* 2.2 ± 2.0 1.7 ± 1.7 3.0 ± 2.1 < 0.001a2
  PHQ-2* 2.1 ± 1.9 1.6 ± 1.6 2.7 ± 2.0 < 0.001a2
  PROMIS Global Mental Healthɫ* 41.5 ± 9.2 44.0 ± 8.8 37.9 ± 8.6 < 0.001a1
  PROMIS Global Physical Healthɫ* 39.7 ± 8.6 42.1 ± 8.3 36.2 ± 7.7 < 0.001a1
  PROMIS fatigue* 62.7 ± 9.1 60.2 ± 8.8 66.2 ± 8.2 < 0.001a1
  Moderate/severe fatigue* 593 (67.2) 294 (57.1) 299 (81.5) < 0.001c
  Severe fatigue* 192 (21.8) 64 (12.4) 128 (34.9) < 0.001c
PROMIS Sleep Disturbance 57.8 ± 8.4 52.3 ± 5.3 65.5 ± 5.3 < 0.001a1
Neuro-QoL Cognitive Function* 39.4 ± 10.0 41.6 ± 10.0 36.4 ± 9.2 < 0.001a1
Sleep study variables (N = 48)
  Study type 0.61d
    Home sleep apnea test 44 (91.7) 22 (95.7) 22 (88.0)
    Polysomnogram 4 (8.3) 1 (4.3) 3 (12.0)
AHI total 15.4 ± 18.9 18.7 ± 24.4 12.4 ± 11.8 0.27a2
Mean oxygen saturation (%)* 92.0 ± 2.3 91.5 ± 2.8 92.5 ± 1.6 0.14a2
% Sleep time O2 < 90 (T90)* 12.1 [2.8,73.3] 16.5 [3.5, 83.2] 9.3 [1.8, 44.3] 0.32a2

BMI, body mass index; COPD, chronic obstructive pulmonary disease; GAD-2, Generalized Anxiety Disorder-2; PHQ-2, Patient Health Questionaire-2; PROMIS, Patient-Reported Outcomes Measurement Information System

*Data not available for all subjects. Missing values: BMI (kg/m2) = 90; GAD-2 = 136; PHQ-2 = 135; PROMIS Global Mental Health = 38; PROMIS Global Physical Health = 30; PROMIS Fatigue = 80; moderate/severe fatigue = 80; severe fatigue = 80; Neuro-QoL Cognitive Function = 126; mean oxygen saturation (%) = 1; sleep time O2 under 90 (%) = 2

ɫHigher scores indicate better health/functioning

Comparisons across sleep disturbance categories were made using Pearson’s chi-square test or Fisher’s exact test for categorical variables and t-test for continuous variables

Statistics presented as mean ± SD, N (column %). p-values: a1 = t-test, a2 = Satterthwaite t-test, c = Pearson’s chi-square test, d = Fisher’s exact test